About this trial
The aim of this study is to evaluate the relationship between ultrasonography-measured quadriceps muscle thickness and the sarcopenia markers SARC-F questionnaire and handgrip strength in patients diagnosed with ischemic stroke. In addition, the relationship between quadriceps muscle thickness and the level of kinesiophobia will be quantitatively assessed.
This study is a cross-sectional clinical study conducted between August 1, 2025, and August 1, 2026, at the Physical Medicine and Rehabilitation Clinic of the University of Health Sciences İstanbul Physical Medicine and Rehabilitation Training and Research Hospital. Fifty volunteer participants with ischemic stroke and a lower-extremity Brunnstrom motor stage of 3 or higher, who presented to the clinic during the study period, were included.
Bilateral quadriceps femoris muscle thickness, including the rectus femoris and vastus intermedius muscles, was measured using ultrasonography. The SARC-F questionnaire was used to assess sarcopenia risk, handgrip strength measurement was used to evaluate muscle strength, and the Tampa Scale for Kinesiophobia was used to determine the level of kinesiophobia. Motor recovery stage was assessed using the Brunnstrom Staging system; motor and cognitive independence were assessed using the Functional Independence Measure; walking independence was assessed using the Functional Ambulation Scale; and independence in activities of daily living was assessed using the Barthel Index of Activities of Daily Living.
Because balance impairment, muscle weakness, and limited mobility are common after stroke, physical performance tests may be difficult to administer safely and consistently in this patient population. Therefore, the relationship between quadriceps muscle thickness and physical performance tests was not evaluated in this study. The Chair Stand Test, which requires repeated sit-to-stand movements as well as adequate balance and lower-extremity muscle strength, was also not included because it may increase the risk of falls in patients with limited mobility.
This study aims to demonstrate the clinical potential of ultrasonography in the assessment of post-stroke sarcopenia and to support a more holistic approach to stroke rehabilitation planning that considers both physical and psychological factors.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Chronic stroke duration between 6 months and 2 years
Ischemic stroke type
Age between 40-80 years
Brunnstrom lower extremity motor stage ≥3, ambulatory
Disqualifiers
Hemorrhagic stroke
Stroke onset more than 2 years prior
Inflammatory arthritis or other rheumatologic disease
History of knee trauma
Trial population
Patients with chronic ischemic stroke who presented to the Physical Medicine and Rehabilitation Clinic of Istanbul Physical Medicine and Rehabilitation Training and Research Hospital.
Trial design
Cohort
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Quadriceps Muscle Thickness
Bilateral quadriceps femoris muscle thickness (rectus femoris and vastus intermedius) measured by ultrasonography
Secondary outcomes
SARC-F Score
Sarcopenia risk was screened using the SARC-F (Strength, Assistance with walking, Rise from a chair, Climb stairs, and Falls) questionnaire, a self-reported 5-item tool. Total score ranges from 0 to 10; higher scores indicate greater risk of sarcopenia.
Handgrip Strength
Handgrip strength was measured using a JAMAR hand dynamometer, expressed in kilograms, as an indicator of functional muscle strength. Higher values indicate greater muscle strength. According to EWGSOP2 criteria, low muscle strength is defined as grip strength \<27 kg in men and \<16 kg in women; values at or above these thresholds are considered normal. There is no fixed maximum value, as grip strength is an open-ended continuous measure
Tampa Scale for Kinesiophobia Score
Kinesiophobia level was assessed using the Tampa Scale for Kinesiophobia (TSK), a self-reported 17-item questionnaire measuring fear of movement/re-injury. Total score ranges from 17 to 68; higher scores indicate greater kinesiophobia.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.